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Abstract
Background: All implant compounds undergo an electrochemical process when in contact with biological fluids, as
well as mechanical corrosion due to abrasive wear, with production of metal debris that may inhibit repair processes.
None of the commonly-used methods can diagnose implant allergies when used singly, therefore a panel of tests
should be performed on allergic patients as pre-operative screening, or when a postoperative metal sensitisation is
suspected.
Methods: We analysed patients with painful prostheses and subjects prone to allergies using the Patch Test in
comparison with the Lymphocyte Transformation Test. Cytokine production was evaluated to identify prognostic
markers for early diagnosis of aseptic loosening. Metal debris endocytosis and cytoskeletal rearrangement was
visualised by confocal microscopy.
Results: Our results demonstrate that the Lymphocyte Transformation Test can identify patients who have a
predisposition to develop allergic reactions and can confirm the diagnosis of hypersensitivity in patients with
painful prostheses.
The prevalence of a Th2-cytokine pattern may be used to identify predisposition to the development of
allergic diseases, while the selective presence of osteoclastogenic cytokines may be used as predictor of a
negative outcome in patients with painful prosthesis.
The hypothesis of the prognostic value of these cytokines as early markers of aseptic loosening is attractive,
but its confirmation would require extensive testing.
Conclusions: The Lymphocyte Transformation Test is the most suitable method for testing systemic allergies. We
suggest that the combined use of the Patch Test and the Lymphocyte Transformation Test, associated with cytokine
detection in selected patients, could provide a useful tool for preventive evaluation of immune reactivity in patients
undergoing primary joint replacement surgery, and for clinical monitoring of the possible onset of a metal sensitization
in patients with implanted devices.
Keywords: Knee arthroplasty, Metal sensitivity, Lymphocyte transformation test, Patch test, Cytokines
Background
Total Knee Arthroplasty (TKA) is one of the most
successful orthopaedic procedures for the treatment of
osteoarthritis [1, 2]. Particularly high rates of patient sat-
isfaction have been achieved in recent decades thanks to
the significant improvement in both surgical technique,
implant design, and the characteristics of biomaterials.
An increasing number of TKAs have been performed
worldwide during recent years as a consequence of the
aging population and a higher incidence of secondary
osteoarthritis in younger patients [3].
Given the high percentage of hypersensitivity to metals
(up to 10%), particularly to nickel, in the general popula-
tion, and the presence of this particular substance in
standard knee implants [4], it may be crucial to verify
the patient’s hypersensitivity prior to surgery, in order to
prevent reactions. This approach is further justified by
the fact that a significant number of failures are ex-
pected to occur over the next few decades due to various
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emerging causes, such as patellar clunk syndrome, peri-
prosthetic fractures, and hypersensitivity to metals [5].
Orthopaedic devices are generally well tolerated, but
may sometimes generate corrosion products which cause
periprosthetic bone resorption; this can lead to implant
looseness and a second surgical procedure may be re-
quired to fix or replace the failed implant [6, 7].
The presence of small amounts of debris that can be
removed through catabolic processes is consistent with
biological tolerance of implants [8, 9], while high con-
centrations of free metal ions may be accumulated in the
surrounding tissue, or carried through the bloodstream to
distant organs [10, 11]. Metal particles bind to serum pro-
teins to form hapten-like complexes that may be identified
by the immune system as antigens, and can activate local
or systemic inflammatory reactions by recruiting macro-
phages, fibroblasts, lymphocytes, and osteoclasts, which
induce proinflammatory and osteoclastogenic cytokine re-
lease [12]. This response, classified as a type-IV delayed
hypersensitivity reaction, is mediated by antigen-presenting
cells and T lymphocytes, and can occur either in the post-
operative period or months and even years later [7, 13].
T cell activation produces a self-perpetuating loop
whereby macrophages are recruited and activated, these
in their turn present a class II major histocompatibility
complex (MHC II) which can activate other sensitised T
cells, and so on. Soluble ions and metal particles may in-
duce monocyte/macrophage activation that stimulates
the inflammatory response by various mechanisms.
Particles can be internalised by phagocytosis, which is
traditionally associated with the expression of MHC II
on macrophages, while soluble ions can penetrate cells
via passive or active transport.
Several studies have demonstrated that cell response
may be affected by the size, shape, quantity and compos-
ition of the debris, and have suggested a possible correl-
ation between the presence of corrosion products and
the symptoms of localized or systemic allergic dermatitis
[14, 15]. Nevertheless, there is no evidence of a direct
link, since immune response changes in relation to the
general state of health, genetic susceptibility, and indi-
vidual hypersensitivity [16].
The incidence of serious adverse reactions requiring im-
plant removal is quite low, but the percentage of patients
with postoperative local inflammatory symptoms, persist-
ent pain, and poorly- functioning implants is not negli-
gible, and demands thorough evaluation. Because the
immune-related mechanisms of metal allergy develop-
ment are not well understood, and several factors may
contribute to overaggressive responses, this phenomenon
may be underrated in the evaluation of persistent post-
surgical pain.
To date, no in vivo and in vitro methods have been spe-
cifically assessed for their efficiency in testing allergies
caused by implants. Patch testing (PT) tends to be used as
the standard test because of its cost-effectiveness and
technical simplicity, but its specific diagnostic useful-
ness is controversial. In fact, there is a remarkable dif-
ference between the immunological reaction deriving
from antigen-presenting cells located in the skin layers
and the systemic response to metal debris, which is
mediated by macrophages and dendritic cells located in
the periprosthetic area. Moreover, screening is not
recommended because hapten exposure may itself
induce sensitization. In addition, visual scoring of skin
reactions is conditioned by the physician’s experience
and may be influenced by medications, the quality of
the substances, and the time of reading [17, 18].
More specific laboratory methods, based on lympho-
cyte proliferation and measurement of cytokine release,
have been proposed: the Lymphocyte Transformation
Test (LTT), which evaluates the proliferative response of
activated T lymphocytes, is based on evidence that aller-
gic individuals produce memory T cells which are able
to be activated by antigen exposure. Moreover, the de-
tection of specific cytokines secreted as the result of an
immune response indicates the qualitative and quantita-
tive involvement of different cell types [19, 20].
Generally, the diagnosis of metal allergy in patients
who have undergone a second surgical procedure due to
the negative outcome of the first one is made by exclu-
sion criteria: lack of evidence of infections, non-union,
and mechanical failure. When an aseptic loosening is
confirmed, revision surgery is the only option. In addition
to the patient’s suffering, the complexity and time-
consuming aspects of the revision procedures, as well as
the related social and economic costs must all also be
taken into account. It is thus useful, in order to choose the
correct implant, to identify which metal is inducing the al-
lergic reactions, [21, 22] both in allergic subjects and in
patients with persistent post-surgical pain. TKA offers a
unique model of study of such condition because it is the
only procedures that may be performed using actual fully
non-allergic implants.
Purpose of this study
We selected a group of patients with a clinical history of
metal allergies who had undergone primary Total Knee
Arthroplasty (pTKA), and a second group of patients
with painful prostheses. Each patient was compared to a
group of control subjects.
The aim of the study was to assess the ability of LTT
and PT to discriminate between skin and systemic reac-
tions. Cytokine production was evaluated to identify
prognostic markers for early diagnosis of aseptic loosen-
ing. Finally, to assess metal endocytosis and cytoskeletal
rearrangement, cell interaction with metal particles was
visualised by confocal microscopy.
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Methods
Patients
Thirty potentially allergic patients, divided into two
groups, were studied. Demographic and clinical data
were collected using a questionnaire. Group 1 included
eight patients scheduled for pTKA, who had a docu-
mented clinical history of metal allergy and hypersensi-
tivity reactions (eczematous rashes, rhinitis, asthma).
Group 2 was composed of twenty-two patients with a
painful TKA. These were evaluated for the nature, loca-
tion, onset and duration of their pain, at least 6 months
postoperatively, and their pain was classified on the basis
of a Visual Analogical Scale ≥7. All signs of the common
causes of failure (infection, instability) were ruled out.
Eleven of the patients referred metal allergies (Group
2A), while the other eleven did not refer any allergies
and had no clinical signs of sensitisation (Group 2B).
All patients were studied by medical history, blood
tests for infection indices (hemochrome, CRP, ESR) and
radiological evaluation (anterior-posterior, lateral and
patellar views, long-standing radiograms, CT scan for
rotational evaluation of components). Functional limita-
tion was measured using a Range of Motion (ROM)
evaluation, and by the Knee Society Score (KSS) and the
Western Ontario and McMaster Universities Osteoarthritis
Index (WOMAC).
Controls (Group 3) included nine volunteers un-
affected by skin disorders or immunological, metabolic,
or chronic diseases, and without any previous known
contact with metal implants.
Patch test
All subjects were tested according to the guidelines sug-
gested by the Società Italiana di Dermatologia Allergologica
Professionale e Ambientale (SIDAPA) based on inter-
national guidelines [23, 24].
Metal allergy was tested by using the following hap-
tens: Cobalt Chloride 1%, Nickel Sulphate 5%, Potassium
Dichromate 0.5%, and Chromium III 2%. (F.I.R.M.A
SpA, Florence, Italy). Vaseline, used as vehicle for patch
test, was assayed as a negative control.
A drop of each hapten was smeared on Haye’s cham-
ber test, which was applied to areas of the left side of
the patient’s upper back that were free of erythema and
dermatitis.
The reading was performed after 48 and 72 h, and
results were recorded based on the second reading. Ac-
cording to the recommendation from the International
Contact Dermatitis Research Group, allergic responses
from 1+ to 3+ were interpreted as a positive reaction, and
were scored as: 1+ (week non-vesicular erythema with
edema and infiltration), 2+ (moderate homogeneous red-
ness, with edema, infiltration and vesicles), and 3+ (strong
homogeneous redness, infiltration and bullous reaction).
A negative reading (0) or a doubtful reaction (+?, only ery-
thema without infiltration) was interpreted as a negative
response [25].
Lymphocyte transformation test
Samples were collected after informed consent and
before PT, to prevent sensitisation. Peripheral Blood
Mononuclear Cells (PBMC) were isolated with Lympho-
cyte Separation Medium and resuspended in RPMI-1640
containing 10% Fetal Bovine Serum. Non-toxic concen-
trations of challenge metals (0,1 mM; 0,01 mM) were se-
lected by a dose response curve. 2 × 105 cells/well were
seeded in triplicate in 96-well plates with or without
Chromium (III) chloride (CrCl3), Chromium powder
(Cr), Nickel (II) chloride (NiCl2), Nickel nanopowder
(Ni), Cobalt powder (Co), Titanium powder (Ti), and
Molybdenum nanopowder (Mo). Ni and Cr, the main
sensitiser metals, were analyzed both in soluble and par-
ticulate form. Phytohemagglutinin (PHA 0,01 mg/ml)
was used as control. After 5 days, cells were pulsed over-
night with 3H-thymidine (1 μCi/well) and proliferation was
assessed by scintillation counting. Results were expressed
as Stimulation Index (SI =mean cpm-treated /mean cpm-
untreated cultures). Culture media and supplements were
purchased from Biowhittaker, (Lonza, Treviglio, Italy),
chemicals from Sigma Aldrich (Milan, Italy).
Luminex cytokine assays
Cytokine production was evaluated in eight Group 1 pa-
tients, four Group 2A patients (all positive to LTT) and
five Controls. Supernatants from metal-challenge PBMC
were collected on day 5 and stored at −80 °C. Luminex
multiplex array (Bio-Rad Laboratories, Hercules, CA,
USA) was used to quantify: IL-1β, IL-1ra, IL-2, IL-4, IL-
5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12, IL-13, IL-15, IL-17,
eotaxin, bFGF, G-CSF, GM-CSF, IFN-γ, IP-10, MCP-1,
MIP-1α, MIP-1β, PDGF-BB, RANTES, TNF-α, VEGF.
Samples were analysed in duplicate using the reagents
and the protocol supplied in the kit.
Out-of-range values (above or below detection limits)
were rated as the highest and the lowest detectable con-
centrations. Cytokine production was expressed as Stimu-
lation Index (SI = value of stimulated cultures/ value of
unstimulated cultures).
Phase-contrast and laser scan confocal microscopy (LSCM)
PBMC (2 × 104 cells/well) were cultured in LabTek
chamber-slides (Thermo Scientific-NUNC, Milan, Italy) for
5 days with or without 0.1 mM and 0.01 mM of selected
metals. Reagents were purchased from Sigma Aldrich
Milan, Italy. Cells were fixed with 4% paraformaldehyde,
permeabilised in 0.2% Triton X-100, and non-specific
binding sites blocked using 2% Bovine Serum Albu-
min. To evaluate the cytoskeletal rearrangement of F-
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actin filaments, samples were stained with Phalloidin
TRITC-conjugate. Nuclei were counterstained with
Hoechst 33258. Samples were mounted in polyvinyl
alcohol mounting medium with anti-fading DABCO
and examined under an Axiovert 200 M inverted
LSM510 (Carl Zeiss, Oberkochen, Germany). Quanti-
tative assessment of cells with internalized metals was
carried out by counting a total number of 200 cells/
well, per metal treatment. Quantification of positive
cells was expressed as the percentage fraction of total
cell numbers counted for each metal.
Statistical analysis
The mean values of SI in allergic patients labelled for
TKA and in patients with painful prostheses were com-
pared to those of control subjects. The differences
among the groups were evaluated using the ANOVA
procedure (STATA statistical package, Stata Corp. 2009
- Stata Statistical Software: Release 10. College Station,
TX: Stata Corp LP), and the REGRESS post estimation
command was used to calculate the p-values of the dif-
ferences between each group of patients (allergic, painful
prosthesis) and control subjects.
Previous literature was analysed to perform a power
calculation. Since several studies did not report effect
size statistics, a raw estimate of an effect size was
achieved using nonparametric statistics reported in con-
ditions which were as similar as possible to ours [26].
The agreement between PT and LTT was estimated in
absolute percentage and by means of the Kappa Statistic
(0–0,20 = poor; 0,21-0,40 = fair; 0,41-0,60 =moderate; 0,61-
0,80 = good; 0,80-1 = very good), which takes chance agree-
ment into account [27].
Results
Considering the relatively small sample size, we tried to
perform a power calculation by analysing previous litera-
ture. Several studies did not report effect size statistics
and often did not provide enough data to compute them.
The raw estimate is between .49 and .64. In our case,
with this effect size, comparing the 4 groups with
ANOVA, the power is between 71 and 91%.
Patch test and lymphocyte reactivity
Since none of the laboratory tests are able to provide
certain diagnoses of allergy, we tried to correlate PT
with the LTT. PT was evaluated according to the clinical
scoring criteria of the International Contact Dermatitis
Research Group [25].
The LTT was considered positive for SI > 2. The en-
hanced proliferation was explained as the expression of
a metal-specific lymphocyte response. All control sub-
jects were found to be negative to PT as well as to the
LTT. The demographic and clinical characteristics of the
30 patients, and their individual reactivity to PT and the
LTT, are summarised in Table 1. The two tests matched
in 60% of cases. A complete correspondence (PT-LTT-
or PT + LTT+) for the same metals was achieved in 37%
of tests. Contradictory results (PT + LTT-) were obtained
in 13% of cases, while (PT-LTT+) in 17%. Doubtful PT
(10%) were ruled out by the LTT (7% negative and 3%
positive responses). The PT and LTT results obtained
for each group of patients are detailed in Table 2.
The observed agreement between the two tests calcu-
lated by the Kappa Statistic, not considering PT as a gold
standard, was 76.6% for all metals tested, with a Kappa
value of 0.3 (fairly good agreement). Similar results were
obtained by comparing the two tests for each metal.
Figure 1a,b shows the effect of sensitiser metals on
lymphocyte response. Mean SI values for each of the 3
patient groups were compared to controls. At the con-
centration of 0.1 mM, (Fig. 1a), NiCl2 produced the
highest degree of proliferative response, with a more
than fivefold increase in Group 1 and Group 2A (5.1
and 5.3 respectively), and a twofold increase in Group
2B. Statistically significant difference was reached in
Group 1 (p = 0.004) and Group 2A (p = 0.001). Moreover,
Ni increased proliferative response by about twofold in
Group 1 and Group 2A (2.2 and 1.7 respectively), with a
statistically significant difference in Group 1 (p = 0.001),
and Group 2A (p = 0.01). Group I patients showed a sta-
tistically significant proliferative response in the presence
of CrCl3 (1.7; p = 0.001) and Cr (1.4; p = 0.03), while
Group 2A patients showed a high proliferative re-
sponse, about a sixfold increase, in the presence of
Co (5.7; p < 0.0001).
At a concentration of 0.01 mM (Fig. 1b), CrCl3 Cr
and Ni did not produce statistically significant re-
sponses. In the presence of NiCl2, Group 1 and Group
2A showed about a twofold increase in proliferative re-
sponse (2; p = 0.01 and 2,1; p = 0.003). Co increased
proliferative response to a lesser extent (1.7; p = 0.01).
Ti and Mo did not produce statistically significant prolif-
erative effects, remaining constantly below the threshold
value of SI < 2. No significant differences were detected
between the two concentrations of sensitiser metals.
Luminex cytokine assays
Although a wide range and sometimes large amounts of
cytokines were produced, only some cytokines reached
statistically significant levels, owing to the low number
of subjects analysed (Fig. 2a-f ).
The ratio of stimulated to unstimulated cultures in
cytokine production was expressed as SI and aver-
aged. Statistically significant differences were obtained
comparing each of the two patient groups with
controls.
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Ti did not activate cytokine production in any of the
analysed cultures.
Cells from allergic patients with no prosthesis revealed
a high reactivity to Ni and a mild reactivity to Mo, Co
and Cr, resulting in the prevalent induction of cytokines
which were indicative of T-cell activation (IL-5, IL-2,
IFNγ) and cytokines associated with monocyte/macro-
phage activation (IL-10).
Cells from allergic patients with painful prostheses
revealed a high reactivity to Cr with statistically signifi-
cant production of IL-7 and IL-12. Increased production
of IL-5, RANTES, IL-7 and IL-17 was observed under
Ni stimulation. Comparison between patients with pain-
ful prostheses and allergic patients showed statistically
significant differences (p = 0,027) only for IL-17. Co in-
duced a statistically significant production of RANTES.
Phase-contrast and laser scan confocal microscopy
Cell interaction with metal particles was visualised by
confocal microscopy, to evaluate cytoskeletal rearrange-
ment and metal endocytosis.
Metal debris within cell cytoplasm can be observed as
non-fluorescent dark areas of different shapes and sizes,
which are not detectable in unstimulated cultures.
Table 1 Overview of demographic and clinical characteristics, and results of PT and LTT




Known allergies Jewelry allergy Cosmetic allergy PT reactivity LTT response
1 F Yes None None Ni Yes None ++++Ni ++++Ni,+Cr,
2 F Yes Yes None Ni Yes Yes ++Ni +++Ni,+Cr,+Ti
3 F Yes None None Ni Yes None ++Ni,+Co +Ni
4 F Yes Yes None Ni Yes None +++Ni +Ni,+Cr
5 F Yes None None Ni,Cr Yes None +Ni Neg
6 F Yes None Yes Ni Yes Yes ++Ni Neg
7 F Yes None None None Yes Yes +Ni +Ni
8 F Yes None None None Yes Yes +/−Ni +Ni
Group 2A
1 F None None None Ni None None ++Ni +Ni
2 F Yes None None None None None ++Co +Ni,+Cr,+Mo
3 F None None Yes Ni Yes None ++Ni ++Ni,+Cr
4 F None None Yes Ni Yes None ++Ni + Ni
5 F Yes None None Ni Yes None ++Ni + Ni
6 F Yes None None Ni Yes None ++Ni ++Ni
7 F Yes None Yes Ni Yes Yes Neg +Ni
8 F Yes None None Ni Yes Yes Neg +Ni
9 M Yes None Yes Ni None Yes Neg +Ni,+Cr,+Co,+Ti
10 F None None None None Yes None Neg +Ni,+Cr
11 M None None None None None None Neg +Ni
Group 2B
12 F Yes Yes None None Yes Yes Neg Neg
13 F Yes None None None None None Neg Neg
14 F Yes None None None None None Neg Neg
15 M Yes None None None None None Neg Neg
16 F Yes None None None Yes Yes Neg Neg
17 F Yes None None None Yes None Neg Neg
18 F None None None None None None Neg Neg
19 F Yes None Yes None Yes None +Cr Neg
20 M Yes None None None None None +Ni,+Co Neg
21 F None None None None None None +/−Co Neg
22 M Yes Yes None None None None +/− Cr Neg
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Generally, Ti, Mo and Co seemed to have non-toxic
effects resulting in well-preserved cell morphology, while
marked cytoskeletal alterations were found following ex-
posure to Ni and Cr. Representative images of cells stim-
ulated by different metals (0.1 mM) are shown in Fig. 3.
Panels A and B represent phase contrast (A1→A8) and
fluorescent images (B1→B8) with overlapping counter-
stained nuclei.
No signs of cellular distress were found in either un-
treated cells (A1, B1) and Ti-stimulated cells (A2, B2).
Some minor cytoskeletal modifications were seen in Co
(A3, B3) and Mo (A4, B4) -treated cells, which in some
cases were similar to controls. Conversely, destruction of
cytoskeletal components was evident in NiCl2 (A5, B5)
and Ni (A6, B6) -treated samples. Moreover, CrCl3 (A7,
B7) and Cr (A8, B8) caused multiple defects in the cyto-
skeleton, and the cytoplasm appeared markedly damaged
or partially destroyed.
Confocal optical sections (z-stacks) confirmed the
internalisation of metal particles, which appeared in
sequential images as multiple dark areas inside the cyto-
plasm (Fig. 4a). Similar results were obtained in all sam-
ples. Representative images are shown in Fig. 4b-f.
Untreated cells (Fig. 4b) showed round or oval shapes,
with central, slightly enlarged nuclei. No dark areas were
observed inside the cytoplasm.
Ti, Mo and Co-stimulated cells appeared similar to
controls (data not shown).
In the attempt to obtain a quantitative evaluation,
the percentages of cells containing metal debris were
calculated.
Generally, high percentages of damaged cells were
found in Ni and Cr-stimulated cells, while low percent-
ages of positive cells were found in Ti, Mo and Co-
stimulated cells, except for the few patients with specific
Ti, Mo or Co-sensitivity.
Similar behavior was observed for the two concentra-
tions of sensitizer metals, but statistical significance was
not reached, owing to the lack of uniformity in cell
counts among the patients. In fact, at the concentration
of 0.1 mM, the percentage of cells containing even a lit-
tle amount of metals, varies from 2 to 17% for Ti, from
2 to 18% for Mo, and from 4 to 22% for Co.
On the other hand, NiCl2 and Ni -treated cells
(Fig. 4c,d) showed clusters of metal debris surrounding
the nucleus, which was still completely enclosed in the
cytoplasm, as well as internalised aggregated particles in
fragmented cells. The percentage of damaged cells varied
from 70 to 82% for NiCl2 and from 47 to 55% for Ni.
Multiple dark holes due to phagocytosed particles were
also found in CrCl3 and Cr-treated cells (Fig. 4e,f ), with
percentage of damaged cells varied from 40 to 48% and
from 40 to 44%, respectively.
Morphological changes, such as disruption of cell
membrane and disappearance of nuclei, indicated severe
cell injury.
Clinical outcome
All Group 1 patients with hypersensitivity diagnosed by
PT and LTT underwent TKA with a non-allergic implant
(Genesis II, Smith & Nephew, Memphis, TN), charac-
terised by an Oxidised Zirconium femoral component,
and all PolyEthylene (PE) tibial and patellar components.
At the 12-month post-surgical evaluation, no compli-
cations were observed, and all patients referred a good
outcome.
On the basis of clinical evidence, seven of the Group
2A patients with hypersensitivity, diagnosed by LTT
alone or PT plus LTT, underwent revision arthroplasty
using a Nickel-free implant with an Oxidized Zirconium
femoral component (Legion OxZr/PE/Ti, Smith & Nephew,
Warsaw, IN) or a Zirconium Nitride multicoating implant
(E-motion multicoating NiZr/PE, BBraun, Melsungen AG).
The other four patients were monitored by a strict follow-
up and treated by pain-controlling drugs, owing to the indi-
vidual risk of possible complications due to concomitant
disease. They underwent revision surgery using the Nickel-
free implant (Legion OxZr/PE/Ti, Smith & Nephew,
Warsaw, IN). At the 12-month postoperative follow-up, no
complications were observed, and patients referred relief
from symptoms and a satisfactory functional recovery. Two
subjects referred clinical improvement, but with persistent
swelling and pain. They are still under observation in order
to understand the reason for this partial recovery.
Group 2B patients, who all showed negative LTT but
different responses to PT, were considered as not allergic
to metals. In three out of eleven patients who had
undergone a second surgical procedure with a Nickel-
Table 2 Number and percentage of stimulatory responses
revealed by PT and LTT
Group 1
Number of cases % Number of cases %
PT+ 7/8 87,5 LTT+ 6/8 75
PT- —— LTT- 2/8 25
PT+/- 1/8 12,5
Group 2A
Number of cases % Number of cases %
PT+ 6/11 54,5 LTT+ 11/11 100
PT- 5/11 45,5 LTT- — —
Group 2B
Number of cases % Number of cases %
PT+ 2/11 18 LTT+ — —
PT- 7/11 64 LTT- 11/11 100
PT+/- 2/11 18
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free implant (Legion OxZr/PE/Ti, Smith & Nephew,
Warsaw, IN), the pain had disappeared. The other pa-
tients, kept under clinical observation and treated with
oral analgesics and periodical steroid drug administra-
tion, referred persistent symptoms and a variable joint
function.
Discussion
Several studies were performed to analyse the possible re-
lationship between metal hypersensitivity and painful or
poorly-functioning prostheses. The individual conditions
which may favour the onset of post-surgical complications
are as yet unknown. None of the clinical or laboratory
analyses prove that these complications may be caused by
metal particles released from implants or by pre-existing
metal sensitivity. Nevertheless, in vitro testing for metal
allergies is recommended for patients undergoing arthro-
plasty who have known hypersensitivity reactions.
In our study, all laboratory results were considered in
the decision-making process, and treatment options
were tailored according to the patient’s needs. Even so,
some patients with painful prostheses referred only a
Fig. 1 a, b Lymphocyte Transformation Test Response. The effect of various metals and PHA on the proliferation rate of patients’ and controls’
lymphocytes: mean lymphocyte response (SI) of each of the three patient groups compared to controls. Group 1 = patients scheduled for pTKA,
labelling for a clinical history of metal allergy; Group 2A = TKA patients with pain and clinical signs of metal allergies; Group 2B = TKA patients
with pain and no clinical signs of metal allergies; Group 3 = Control subjects. Metal concentrations: (a) = 0.1 mM; (b) = 0,01 mM. Asterisks indicate:
(*) p < 0.05; (**) p < 0.005; (***) p < 0.0001
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partial recovery after revision surgery. As discussed else-
where, the persistence of post-surgical pain is not clearly
defined [28, 29], but Macrae reports that surgery itself is
the second most common cause of this problem [30]. A
high failure rate in a revision series (about 80%) has
been reported in cases of undefined pain origin [31].
The persistence of pain may be a consequence of under-
lying conditions, or of surgical complications. Wylde et
al. assess that 44% of patients undergoing TKA suffer
from persistent post-surgical pain of varying severity
[32] and revision surgery may also lead to uncertain
clinical results.
These data highlight the need to have as much informa-
tion as possible concerning the nature of pain. Moreover,
there is an urgent need to develop in vitro tests to achieve
better understanding of this problem. Current laboratory
methods, used individually, failed to provide a sure diag-
nosis. To offset the limitations of each method, a com-
bined approach evaluating both PT and LTT was used to
detect systemic metal reactivity. When a diagnostic test is
Fig. 2 a-f Cytokine production in response to metals. Cytokine production in response to metals (0.1 mM and 0.01 mM) in the two patient
groups compared to controls. Group 1 = patients scheduled for pTKA, labelling for a clinical history of metal allergy; Group 2A = TKA patients with
pain and clinical signs of metal allergies; Group 2B = TKA patients with pain and no clinical signs of metal allergies; Group 3 = Control subjects.
Metals: (a) = Chromium chloride; (b) = Chromium; (c) = Nickel chloride; (d) = Nickel; (e) = Cobalt; (f) = Molybdenum. (SI = mean of Stimulation
Index). Asterisks indicate: (*) p < 0.05; (**) p < 0.005
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unable to specifically identify a clinical condition, it must
be double-checked with another test to confirm a prelim-
inary diagnosis or clarify contradictory responses.
PT may not reflect the immunological response at the
implant site. A positive PT indicates an allergen-specific
cutaneous reaction, but does not clearly signify the de-
velopment of metal sensitivity. PT itself may also induce
sensitization. Moreover, strong reactions indicate true
positivity, but it is very difficult to interpret a doubtful
result [33]. Nevertheless, it must always be considered
within the overall clinical context, or be supported by
other findings. Only more in-depth analysis can rule out
or confirm allergic response and identify the specific
sensitiser metal.
LTT may be more useful than PT in allergic patients,
ruling out a direct contact with allergens as well as
doubtful PT results. Therefore, considering that PT
alone is inadequate for formulating a diagnosis or for de-
ciding on revision surgery, we explored the potential of
LTT as a confirmatory test. The limited agreement be-
tween PT and LTT shown by the Kappa coefficient is
probably due to the small cohorts analysed.
A5 B5 B6A6
A7 B7 A8 B8
A3 B3 B4A4
A1 B1 B2A2
Fig. 3 Phase-contrast microscopy. Representative images of cells stimulated by different metals (0.1 mM). Panels a and b represent phase
contrast (A1→A8) and fluorescent images (B1→B8), overlapped with counterstained nuclei. (A1-B1: untreated cells; A2-B2: Ti; A3-B3: Co; A4-B4: Mo;
A5-B5: NiCl2; A6-B6: Ni; A7-B7: CrCl3; A8-B8: Cr-treated samples. (Phalloidin TRITC-conjugate and Hoechst 33258). (1-3; 5-7 = 40× original
magnification), (4; 8 = 63× original magnification)
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Sometimes PT reactivity was not confirmed by LTT.
False-positive or negative reactions in patients affected
with contact dermatitis have been documented by
Brasch et al. and Sarma [34, 35]. In our experimental
conditions, 87% of Group 1 patients tested positive to
PT. LTT confirmed and sometimes expanded the diag-
nosis of metal reactivity in 75% of cases. Negative LTT
results were explained as skin-specific sensitivity.
All Group 2A patients were found positive to LTT but
only 55% to PT. This may be indicative of a systemic sen-
sitisation, but it means that PT failed to identify sensitised
subjects in 45% of cases. At the same time, all Group 2B
patients were found negative to LTT. Again, a clearly
negative response to PT was detected in only 64% of cases.
Since comparison with other methods is lacking, this con-
stitutes a serious limit to the clinical decision process.
These results supported our working hypothesis, whereby
LTT is a more suitable method for testing systemic allergies
and differentiating dermal from implant-induced hyper-
sensitivity reactions. However, the lack of overlap
suggests that these tests are complementary but not
equivalent. In fact, they recognise different biological
mechanisms which are only partially correlated. This is
borne out by the comparison of mean LTT SI values
among the 4 groups. In fact, allergic subjects affected
by knee arthritis and hypersensitivity to metals diag-
nosed by PT and LTT had comparable SI values to
those of patients with painful arthroplasty, while pa-
tients with painful arthroplasty but no clinical signs of
sensitisation showed similar results to controls. No
significant differences were detected between the two






Fig. 4 a-f Confocal Microscopy. Representative images of z-stacks optical sections (a), untreated cells (b), NiCl2 (c), Ni (d), CrCl3 (e), and Cr (f) -stimulated
cells. (Phalloidin TRITC-conjugate, Hoechst 33258). (Phalloidin TRITC-conjugate, Hoechst 33258). b = 40x, c,e = 63x, d,f = 100x original magnification
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LTT response to NiCl2 and Ni was significantly higher
in Group 1 and Group 2A patients. Statistically signifi-
cant effects were also determined by CrCl3 and Cr in
Group 1 patients, despite the fact that all values con-
stantly remained below the SI threshold value.
Interestingly, Co produced a remarkable degree of pro-
liferative response only in Group 2A patients. The high
statistical significance of these findings is consistent with
the clinical characteristics of these patients. Moreover, a
dose–response relation between the two metal concentra-
tions was also observed. No statistically significant differ-
ences in Ti and Mo responses were detected among the
four groups.
These findings showed that positive LTT response
may indicate patients who have a predisposition to de-
velop pathological reactions to implanted devices, and
confirm the suspicion of metal allergy in patients with
painful prostheses. Thus in case of limited resources, we
suggest that LTT should be preferred to PT.
Cytokine assay may be reserved for patients undergo-
ing revision surgery.
Regarding cytokine production, in allergic patients
with no prosthesis Ni caused a statistically significant in-
crease in IL-5, which is considered an allergen-specific
cytokine. Czarnobilska et al. showed that Nickel-induced
IL-5 production is related to the intensity of PT
response and might be a useful marker to distinguish be-
tween allergic and non-allergic subjects [36].
IL-5 was also reported to be secreted in vitro by
nickel-stimulated peripheral blood mononuclear cells in
Ni-allergic patients. All these results indicate that type 2
response might contribute to the immunopathogenesis
of contact hypersensitivity [37–39].
Also a statistically significant increase in IL-2 was evi-
denced, in agreement with previous reports that indicate
IL-2 as an early occurring type-1cytokine in patients
with Ni allergic contact dermatitis [40].
A statistically significant production of RANTES,
which may recruit leukocytes at the site of inflammation,
was found. Other cytokines potentially involved in aller-
gic responses (IL-4, IL-9) were detected. IL-7 regulates
Th1/Th2 cytokine production, while IL-2 and IL-10 can
play immune-suppressive or stimulatory roles. An
increase in IL-2 and a decrease in IFN-γ may induce a
switch of the T helper lymphocytes. The up-regulation
of Th2 and Th9 cells and the down-regulation of Th1
cells reveal a typical allergic pattern in this group of pa-
tients. All these data are coherent with the significantly
higher proliferative response to Ni, found by the LTT
test, in this group.
In allergic patients with painful prostheses the high re-
activity to Co enhanced the production of RANTES, which
may recruit leukocytes at the inflammation site. Other
metals induced the production of cytokines associated with
monocyte-macrophage activation, which plays a role in the
regulation of type1/type2 cytokine balance (IL-12). Elevated
IL-12 levels have been reported by Inomoto et al. in the
pseudosynovial fluid of patients with aseptic loosening of
hip prostheses [41].
A statistically significant increase was observed in IL-7
production under Cr stimulation and IL-17 production
under Ni stimulation. These osteogenic cytokines can
stimulate RANKL production. As is known, the RANK-
RANKL system stimulates osteoclast activation, increas-
ing bone resorption [42, 43]. Increased levels of these
cytokines are consistent with the clinical characteristics
of the patients analysed, and can be related to implant
failure. Also in this group of patients the increased re-
sponse to Ni and Co observed by LTT are coherent with
the production of osteoclastogenic cytokines which are
specific for these patients.
This is in accordance with Summer B. et al. that showed
that patients with complicated total joint arthroplasty and
concomitant Ni patch test reactivity had a predominant
IL-17 response. This suggests that a potentially increased
risk of complications following prosthesis implantation
might be based on the evaluation of IL-17 [4].
Regarding the cytokine profile, the observed data are
insufficient to support the need for routine cytokine
assay as a preliminary test. In our experimental condi-
tions, a different response was found in the two patient
groups. All metals induced a mixed Th1 and Th2-type
cytokine production. Despite the small number of cases,
the prevalence of a Th2-cytokine pattern may be used to
identify predisposition to the development of allergic dis-
eases. At the same time, the selective presence of osteo-
clastogenic cytokines as IL-17 and IL-7 and the evidence
of RANTES and IL-12, may be used as predictors of a
negative outcome in patients with painful prosthesis.
However, because of the high inter-individual and
intra-individual variability of cytokine expression, a
population study needs to be performed to ascribe prog-
nostic values to specific cytokines.
An alternative approach is represented by molecular
analysis of cytokine pattern together with histological
evaluation of the periimplant tissue, in patients undergo-
ing revision surgery.
Hercus B. et al. analyzed mRNA expression of TH1
(IFN- γ, TNF- β, IL-2, IL-12) and TH2 (IL-4, IL-5, IL-6,
IL-10) cytokines present at the bone-implant interface of
aseptically loosened joints, and demonstrated a predom-
inance of TH1 over TH2 response [44].
Recently, Thomas suggested a combined approach to
evaluate a possible link between a specific cytokine
expression pattern and periimplant tissue analysis, in pa-
tients with TKA failure. An high expression of IFN- γ
and IL-2 was evidenced with semiquantitative real-time
RT-PCR [26, 45].
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Regarding histological analysis of periprosthetic tissues,
past investigations evidenced the presence of metallic
aggregates in the perilesional area, as well as perivascular
infiltrations of T-cells and macrophages in the tissue sec-
tions [46, 47].
Davies A.P. et al. described arthroplasty failure in asso-
ciation with the histological evidence of periprosthetic
lymphocytic infiltration and macrophage containing
metal debris [48].
Witzleb W.C. et al. reported that the presence of diffuse
and perivascular lymphocytic infiltration in periprosthetic
tissue may be considered to be a characteristic histological
pattern of tissue reactions to metal particles [49].
Other Authors analysed some histological parameters
and cytokine levels in tissue and synovial fluids from pa-
tients undergoing primary total hip/knee replacement
and from patients requiring revision for aseptic loosen-
ing. Statistically significant increases in cytokine levels
and in macrophage infiltrate were found in samples from
patients with aseptic loosening, compared to patients
undergoing primary surgery [50, 51].
For histopathological classification of the hypersensi-
tivity reactions in periprosthetic tissue, a standardized
consensus classification was established [52].
Nevertheless, microscopy approach remains a qualita-
tive method, generally referred to limited groups of cells.
Other limitations have arisen from the heterogeneity of
implant devices, source and location of tissue samples,
patient characteristics and because of the absence of
proper control groups.
All of these investigations concern patients requiring
hip or knee revision surgery for ascertain aseptic loosen-
ing of prosthesis.
Our study design aimed to identify common labora-
tory methods for the preventive evaluation of potentially
allergic patients and for the early diagnosis of aseptic
loosening in patients whit painful prosthesis.
Phase-contrast microscopy was preliminarily used on
PBMC to reveal changes in cytoskeletal structure, and
Laser Scan Confocal analysis was applied to visualise
solid particles internalisation and their effects on cyto-
skeleton rearrangement.
Generally speaking, phase-contrast microscopic evalu-
ation revealed that Ti, Mo and Co had non-toxic effects
resulting in well-preserved cell morphology.
Conversely, after exposure to Ni and Cr, the number
of cells appeared to be strongly reduced and marked
cytoskeletal alterations were revealed.
Also LSCM observation confirmed the relatively low
toxicity of Ti, Mo and Co, while under Ni and Cr stimu-
lation, an high percentage of cells with a considerable
amount of metals inside was evidenced. Enlarged cells
with multiple defects in cytoskeletal organisation, caused
by individual and aggregated internalised particles in
perinuclear areas, confirmed the cytotoxic effect of these
metals.
Phase-contrast and Laser Scan Confocal microscope
observations of PBMC did not provide a statistically sig-
nificant quantitative evaluation. However, no diagnostic
response, but only the proof of metal particles internal-
ization, was expected.
Conclusions
In conclusion, to achieve an improvement in clinical prac-
tice, a PT confirmed by LTT could be introduced as stand-
ard procedure. This would allow the identification of
subjects who are likely to develop implant-related hyper-
sensitivity reactions. At the same time, it would avoid the
development of allergies from joint implantation, and
reveal any reactions due to implant compounds.
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